Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
aripiprazol krka tafla 30 mg
krka sverige ab - aripiprazolum inn - tafla - 30 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
aripiprazol w&h tafla 5 mg
williams & halls ehf. - aripiprazolum inn - tafla - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
aripiprazol krka tafla 15 mg
krka sverige ab - aripiprazolum inn - tafla - 15 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
aripiprazol krka tafla 10 mg
krka sverige ab - aripiprazolum inn - tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
aripiprazol krka tafla 5 mg
krka sverige ab - aripiprazolum inn - tafla - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
aripiprazol w&h tafla 10 mg
williams & halls ehf. - aripiprazolum inn - tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
aripiprazole medical valley tafla 10 mg
medical valley invest ab - aripiprazolum inn - tafla - 10 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
aripiprazole medical valley tafla 5 mg
medical valley invest ab - aripiprazolum inn - tafla - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
nanogam innrennslislyf, lausn 50 mg/ml
prothya biosolutions netherlands b.v. - immunoglobulinum humanum inn - innrennslislyf, lausn - 50 mg/ml
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.